The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro

Autor: Salpini, R., Surdo, M., Cortese, M.F., Palumbo, G.A., Carioti, L., Cappiello, G., Spanò, A., Trimoulet, P., Fleury, H., Vecchiet, J., Pasquazzi, C., Mirabelli, C., Scutari, R., Sacco, A., Alkhatib, M., Missale, G., Francioso, S., Sarmati, L., Andreoni, M., Angelico, M., Ceccherini-Silberstein, F., Levrero, M., Perno, C.F., Belloni, L., Svicher, V.
Zdroj: In Clinical Microbiology and Infection July 2019 25(7):906-906
Databáze: ScienceDirect